Therapeutic Area market research reports by DelveInsight

• Oncolytic Virus Cancer Therapy - Market Insight, Epidemiology and Market Forecast – 2032

  Sep 01, 2022  |  Published by: DelveInsight  |  USD 7,500

  Oncolytic Virus Cancer Therapy - Market Insight, Epidemiology and Market Forecast – 2032 DelveInsight's "" Oncolytic Virus Therapies (OVTs)- Market Insight, Epidemiology and Market Forecast Forecast-2032"" report delivers an in-depth understanding of the Oncolytic Virus Therapies (OVTs), historical ... Read More

• EXSERVAN Drug Insight and Market Forecast – 2032

  Sep 01, 2022  |  Published by: DelveInsight  |  USD 2,750

  EXSERVAN Drug Insight and Market Forecast – 2032 “EXSERVAN Drug Insight and Market Forecast – 2032” report provides comprehensive insights about EXSERVAN for Amyotrophic Lateral Sclerosis in seven major markets. A detailed picture of the EXSERVAN for Amyotrophic Lateral Sclerosis in 7MM, i.e., Unite ... Read More

• Hematological Cancer (Blood Cancer) Therapeutics- Market Insights, Competitive Landscape and, Market Forecast - 2027

  Sep 01, 2022  |  Published by: DelveInsight  |  USD 2,750

  Hematological Cancer (Blood Cancer) Therapeutics- Market Insights, Competitive Landscape and, Market Forecast - 2027 Hematological Cancer (Blood Cancer) Therapeutics By Indication (Leukemia, Lymphoma, And Myeloma), By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, And Other Therapies), By E ... Read More

• Progressive Pulmonary Fibrosis (PPF) - Market Insights, Epidemiology, and Market Forecast–2032

  Sep 01, 2022  |  Published by: DelveInsight  |  USD 7,500

  Progressive Pulmonary Fibrosis (PPF) - Market Insights, Epidemiology, and Market Forecast–2032 DelveInsight’s ‘Progressive pulmonary fibrosis (PPF) - Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the Progressive pulmonary fibrosis (PPF), histori ... Read More

• VRAYLAR Emerging Drug Insight and Market Forecast – 2032

  Sep 01, 2022  |  Published by: DelveInsight  |  USD 3,250

  VRAYLAR Emerging Drug Insight and Market Forecast – 2032 “VRAYLAR, Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about VRAYLAR for Treatment Resistant Depression in seven major markets. A detailed picture of the VRAYLAR for Treatment Resistant Depression in ... Read More

• Chronic Refractory Cough - Market Insight, Epidemiology And Market Forecast - 2032

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 7,500

  Chronic Refractory Cough - Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight’s ‘Chronic Refractory Cough-Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the Chronic Refractory Cough, historical and forecasted epidemiology as wel ... Read More

• Chlamydia Infections - Pipeline Insight, 2022

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  Chlamydia Infections - Pipeline Insight, 2022 DelveInsight’s, “Chlamydia Infections - Pipeline Insight, 2022,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Chlamydia Infections pipeline landscape. It covers the pipeline drug profiles, including clinical and nonc ... Read More

• Progressive Fibrosing Interstitial Lung Disease Market Insight, Epidemiology And Market Forecast - 2032

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 7,500

  Progressive Fibrosing Interstitial Lung Disease Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight’s ‘Progressive Fibrosing Interstitial Lung Disease (PF-ILD)- Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the Progressive Fibro ... Read More

• Idiopathic Pulmonary Fibrosis - Market Insight, Epidemiology And Market Forecast - 2032

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 7,500

  Idiopathic Pulmonary Fibrosis - Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight’s ‘Idiopathic Pulmonary Fibrosis -Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the Idiopathic Pulmonary Fibrosis , historical and forecasted ep ... Read More

• Chronic hand eczema - Pipeline Insight, 2022

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  Chronic hand eczema - Pipeline Insight, 2022 DelveInsight’s, Chronic hand eczema - Pipeline Insight, 2022,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Chronic hand eczema pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclini ... Read More

• Allergic Rhino-Conjunctivitis - Pipeline Insight, 2022

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  Allergic Rhino-Conjunctivitis - Pipeline Insight, 2022 DelveInsight’s, “Allergic Rhino-Conjunctivitis - Pipeline Insight, 2022,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Allergic Rhino-Conjunctivitis pipeline landscape. It covers the pipeline drug profiles, ... Read More

• Pneumonia, Pneumococcal - Pipeline Insight, 2022

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 1,500

  Pneumonia, Pneumococcal - Pipeline Insight, 2022 DelveInsight’s, Pneumonia, Pneumococcal - Pipeline Insight, 2022,” report provides comprehensive insights about 12+ companies and 15+ pipeline drugs in Pneumonia, Pneumococcal pipeline landscape. It covers the pipeline drug profiles, including clinica ... Read More

• Dysmenorrhea - Pipeline Insight, 2022

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  Dysmenorrhea - Pipeline Insight, 2022 DelveInsight’s, “Dysmenorrhea – Pipeline Insight, 2022,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Dysmenorrhea pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. ... Read More

• VRAYLAR, Emerging Drug Insight and Market Forecast – 2032

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 3,250

  VRAYLAR, Emerging Drug Insight and Market Forecast – 2032 “VRAYLAR, Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about VRAYLAR for Treatment Resistant Depression in seven major markets. A detailed picture of the VRAYLAR for Treatment Resistant Depression i ... Read More

• Low-grade glioma - Market Insights, Epidemiology and Market Forecast– 2032

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 7,500

  Low-grade glioma - Market Insights, Epidemiology and Market Forecast– 2032 DelveInsight's "" Low-grade glioma - Market Insights, Epidemiology and Market Forecast– 2032” report delivers an in-depth understanding of the LGG, historical and forecasted epidemiology as well as the LGG market trends in th ... Read More

• Diabetic Gastroparesis - Pipeline Insight, 2022

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  Diabetic Gastroparesis - Pipeline Insight, 2022 DelveInsight’s, “Diabetic Gastroparesis - Pipeline Insight, 2022,” report provides comprehensive insights about 6+ companies and 8+ pipeline drugs in Diabetic Gastroparesis pipeline landscape. It covers the pipeline drug profiles, including clinical an ... Read More

• Pancreatic Cancer - Market Insight, Epidemiology And Market Forecast - 2032

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 9,500

  Pancreatic Cancer - Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight’s ‘Pancreatic Cancer - Market Insights, Epidemiology, and Market Forecast–2032’ report delivers an in-depth understanding of the pancreatic cancer historical and forecasted epidemiology as well as the pancreatic ... Read More

• Gastrointestinal Stromal Tumor (GIST) - Market Insight, Epidemiology And Market Forecast - 2032

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 7,500

  Gastrointestinal Stromal Tumor (GIST) - Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight’s ‘Gastrointestinal Stromal Tumor (GIST)-Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the GIST, historical and forecasted epidemiology ... Read More

• Wet Age-Related Macular Degeneration (Wet-AMD) - Pipeline Insight, 2022

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 2,500

  Wet Age-Related Macular Degeneration (Wet-AMD) - Pipeline Insight, 2022 DelveInsight’s, “Wet Age-Related Macular Degeneration (Wet-AMD) - Pipeline Insight, 2022,” report provides comprehensive insights about 70+ companies and 80+ pipeline drugs in Wet Age-Related Macular Degeneration (Wet-AMD) pipel ... Read More

• Tinea Pedis - Pipeline Insight, 2022

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  Tinea Pedis - Pipeline Insight, 2022 DelveInsight’s, Tinea Pedis - Pipeline Insight, 2022,” report provides comprehensive insights about 5+ companies and 7+ pipeline drugs in Tinea Pedis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It a ... Read More

• Uveal Melanoma - Pipeline Insight, 2022

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 2,000

  Uveal Melanoma - Pipeline Insight, 2022 DelveInsight’s, “Intraocular(Uveal) melanoma – Pipeline Insight, 2022,” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Intraocular(Uveal) melanoma pipeline landscape. It covers the pipeline drug profiles, including clinic ... Read More

• SLS-005 Emerging Drug Insight and Market Forecast – 2032

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 3,250

  SLS-005 Emerging Drug Insight and Market Forecast – 2032 “SLS-005 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about SLS-005 for Amyotrophic Lateral Sclerosis in the 7MM. A detailed picture of the SLS-005 for Amyotrophic Lateral Sclerosis in the 7MM, i.e., ... Read More

• Acute Respiratory Distress Syndrome (ARDS) - Market Insight, Epidemiology And Market Forecast - 2032

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 9,500

  Acute Respiratory Distress Syndrome (ARDS) - Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight’s ‘Acute Respiratory Distress Syndrome-Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the Acute Respiratory Distress Syndrome, histo ... Read More

• Sinusitis - Pipeline Insight, 2022

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 2,000

  Sinusitis - Pipeline Insight, 2022 DelveInsight’s, “Sinusitis - Pipeline Insight, 2022,” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Sinusitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also ... Read More

• Large Granular Lymphocytic Leukemia (LGLL)- Market Insights, Epidemiology, and Market Forecast-2032

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 7,500

  Large Granular Lymphocytic Leukemia (LGLL)- Market Insights, Epidemiology, and Market Forecast-2032 DelveInsight's "" Large Granular Lymphocytic Leukemia (LGLL)- Market Insights, Epidemiology, and Market Forecast-2032"" report delivers an in-depth understanding of the LGLL, historical and forecasted ... Read More

< prev 23 24 25 26 27 28 29 30 31 32 next >